首页 › 基金 › ADAR1 Capital Management, LLC › PTGX

ADAR1 Capital Management, LLC 对 PTGX 的持仓历史

PROTAGONIST THERAPEUTICS INC · 医疗保健

ADAR1 Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 PTGX(PROTAGONIST THERAPEUTICS INC)951,403 股,市值约 US$134.0M,约占其申报组合的 7.36%,在其申报持仓中市值排名第 2 位。 ADAR1 Capital Management, LLC 最近 12 个申报季度中有 12 个季度披露了 PTGX 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)951.40K 股
申报持仓市值$134.04M
组合权重7.36%
首次申报Q4 2023
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

ADAR1 Capital Management, LLC 对 PTGX 的持仓演变

ADAR1 Capital Management, LLC 于 Q4 2023 首次披露 PTGX 持仓:200,859 股(约 US$4.6M)。 该持仓在 Q3 2026 达到峰值 951,403 股,市值约 US$134.0M。 在 12 次申报中,ADAR1 Capital Management, LLC 6 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 951,403 股、市值约 US$134.0M,环比减持 -9,460 股。。 持仓曾出现大幅变动:Q1 2024 增持约 291% (随后一个季度股价上涨 20%)、Q2 2024 增持约 104% (随后一个季度股价上涨 30%)、Q1 2025 增持约 612% (随后一个季度股价上涨 14%)。

逐季持仓明细

季度股数金额变化
Q4 2023 200.86K $4.61M 新进
Q1 2024 785.65K $22.73M 增持
Q2 2024 1.60M $55.58M 增持
Q3 2024 981.29K $44.16M 减持
Q4 2024 132.00K $5.10M 减持
Q1 2025 939.67K $45.44M 增持
Q2 2025 948.07K $52.40M 增持
Q3 2025 989.18K $65.71M 增持
Q4 2025 1.05M $91.63M 增持
Q1 2026 994.12K $104.78M 减持
Q2 2026 960.86K $117.78M 减持
Q3 2026 951.40K $134.04M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PTGX 与 13F 数据

PTGX(PROTAGONIST THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 PTGX,申报仓位最大的包括:FARALLON CAPITAL MANAGEMENT, L.L.C. (US$907.0M), 法拉龙资本管理 (US$778.2M), RTW INVESTMENTS, LP (US$713.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PTGX 的基金

查看 PTGX 的全部基金持有人 →

常见问题

How long has ADAR1 Capital Management, LLC held PTGX?

ADAR1 Capital Management, LLC has disclosed PTGX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in PTGX?

As of Q3 2026, ADAR1 Capital Management, LLC holds 951.40K shares of PTGX (PROTAGONIST THERAPEUTICS INC), valued at $134.04M, representing 7.36% of its reported portfolio and ranking #2.

Has ADAR1 Capital Management, LLC been buying or selling PTGX?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in PTGX. The position peaked in Q3 2026 at 951.40K shares.

Which other funds hold PTGX?

Other major institutional holders of PTGX include FARALLON CAPITAL MANAGEMENT, L.L.C., 法拉龙资本管理, RTW INVESTMENTS, LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.